Coverage
Filings
| Filing | Date |
|---|---|
| Director/PDMR Shareholding | 25 Oct 2023 |
| Director/PDMR Shareholding | 20 Oct 2023 |
| Director/PDMR Shareholding | 18 Oct 2023 |
| Director/PDMR Shareholding | 17 Oct 2023 |
| Jemperli plus chemotherapy positive CHMP opinion | 16 Oct 2023 |
| Director/PDMR Shareholding | 13 Oct 2023 |
| Director/PDMR Shareholding | 12 Oct 2023 |
| Zantac (ranitidine) litigation | 11 Oct 2023 |
| GSK and Zhifei announce vaccine partnership |
GSK said Monday it has appointed Chief Commercial Officer Luke Miels as its next chief executive, succeeding Dame Emma Walmsley.
GSK PLC announced plans to invest $30 billion in the United States over the next five years to boost its research, development, and manufacturing capabilities.
GSK said on Monday that the U.S. Food and Drug Administration has accepted for review its application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to at-risk adults aged 18 to 49.
| 9 Oct 2023 |
| GSK completes sale of shares in Haleon plc | 6 Oct 2023 |
| GSK announces intention to sell shares in Haleon | 5 Oct 2023 |
| Total Voting Rights | 2 Oct 2023 |